HP&M Director to Moderate at FDLI REMS ConferenceMay 11, 2011
Hyman, Phelps & McNamara, P.C., Director Josephine M. Torrente will be moderating a session at the Food and Drug Law Institute’s (“FDLI’s”) upcoming 1-day conference on Risk Evaluation and Mitigation Strategies (“REMS”), which were created under the 2007 FDA Amendments Act. The FDLI conference, for which Ms. Torrente also served on the planning committee, is titled “Issues and Answers: Advancing Risk Evaluation and Mitigation Strategies and Benefit-Risk Management to the Next Level,” and will feature cutting-edge presentations by FDA and industry experts followed by panel discussions to further explore the implications of the presentations. The conference will take place on May 19, 2011 at the Westin City Center in Washington, DC.
Ms. Torrente’s panel session, titled “From Qualitative to Quantitative-Benefit Risk Models and Patient Perspectives,” will consider the pros and cons of the existing qualitative methods and the evolving quantitative models in REMS considerations. Other panel sessions include “Advances in REMS Risk Communications,” “The State of REMS and Benefit Risk Management,” and “Measuring the Effectives of REMS Tools and Programs to Date.”
Additional information on the FDLI conference, including registration information, is available on FDLI’s website here.